---
title: "KEOGH BRIAN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/30acd2fc-2d0c-5c52-887e-00d5ab4dbcaa
json: https://whiteintel.dev/api/public/dossier/30acd2fc-2d0c-5c52-887e-00d5ab4dbcaa
jurisdiction: ES
source: WhiteIntel corporate-ownership graph
---

# KEOGH BRIAN

**Type:** Person  
**Jurisdiction:** ES  
**Canonical dossier:** https://whiteintel.dev/entity/30acd2fc-2d0c-5c52-887e-00d5ab4dbcaa  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/30acd2fc-2d0c-5c52-887e-00d5ab4dbcaa  

## Ownership & control

### Holdings / subsidiaries

- **AMICUS THERAPEUTICS SL** (Director) — https://whiteintel.dev/entity/f4983152-3376-561b-9f3b-1746a6e112cb
- **BIOMARIN PHARMACEUTICALS ESPAÑA SL** (Attorney (joint)) — https://whiteintel.dev/entity/0ff624de-a925-5570-b5da-e05c8763ca19

## Provenance

- borme — https://www.boe.es/datosabiertos/

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KEOGH BRIAN**. Human view: https://whiteintel.dev/entity/30acd2fc-2d0c-5c52-887e-00d5ab4dbcaa · Structured JSON: https://whiteintel.dev/api/public/dossier/30acd2fc-2d0c-5c52-887e-00d5ab4dbcaa._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._